Atrandi Biosciences vs ThinkCyte

Atrandi Biosciences logo

Atrandi Biosciences

Semi-Permeable Capsules (SPCs) for single-cell analysis and multiomics at scale

79 employees · est. 2016 · Vilnius, Lithuania

VS
ThinkCyte logo

ThinkCyte

Deeper insights, better treatments - a single cell at a time

51 employees · est. 2016 · Japan

Side-by-Side Comparison

Atrandi Biosciences ThinkCyte
Founded
2016 2016
Headquarters
Vilnius, Lithuania Japan
Employees
79 51
Industry
Biotechnology, Life Sciences, Pharmaceutical Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Series A Corporate Round
Total Funding
$30.80M $5.15B
Funding Rounds
3 5
Services
Development of single-cell analysis platforms, Multi-step multi-omic workflow facilitation, High-throughput screening solutions, Custom droplet and SPC workflow design VisionSort Platform, MorphoScan Cloud, Instrument Service, Consumables
Target Customers
Biomedical Researchers, Laboratories focusing on genomics, Biotech companies, Academia engaged in single-cell studies, Scientists developing next-gen screening assays Pharmaceutical Companies, Biotechnology Firms, Research Laboratories, Clinicians in Regenerative Medicine
Taxonomy
Semi-Permeable CapsulesSingle-Cell AnalysisMultiomicsGenomicsMicrofluidicsHigh-Throughput Screening +7 Single-Cell TechnologyBiological DiscoveriesNovel TreatmentsAdvanced HardwareSingle-Cell AnalysisDiagnostics +6
Website
atrandi.com thinkcyte.com
Atrandi Biosciences logo

About Atrandi Biosciences

Atrandi Biosciences is a forward-thinking company founded in 2016 and based in Lithuania. Specializing in the Biotechnology, Life Sciences, and Pharmaceutical industries, the company has developed a patented technology known as Semi-Permeable Capsules (SPCs). This innovation offers transformative po...

ThinkCyte logo

About ThinkCyte

ThinkCyte, founded in 2016 and headquartered in Japan, stands at the forefront of innovation in the Biotechnology, Health and Wellness, and Life Sciences industries. With the slogan, "Deeper insights, better treatments - a single cell at a time," the company delivers on its mission to revolutionize...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Atrandi Biosciences and ThinkCyte for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Atrandi Biosciences or ThinkCyte moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Atrandi Biosciences was founded in 2016, based in Vilnius, Lithuania, with 79 employees. Atrandi Biosciences is a forward-thinking company founded in 2016 and based in Lithuania. Specializing in the Biotechnology, Life Sciences, and Pharmaceutical industries, the company has developed a p. ThinkCyte was founded in 2016, based in Japan, with 51 employees. ThinkCyte, founded in 2016 and headquartered in Japan, stands at the forefront of innovation in the Biotechnology, Health and Wellness, and Life Sciences industries. With the slogan, "Deeper insights,.
Atrandi Biosciences has raised $30.80M and ThinkCyte $5.15B. Latest stage: Atrandi Biosciences Series A, ThinkCyte Corporate Round.
Both work in Biotechnology and Life Sciences and list single-cell analysis among their focus areas.

Compare Atrandi Biosciences with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Atrandi Biosciences on 15 Jun 2026, and ThinkCyte on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes